HRA Pharma separates rare diseases portfolio

15 July 2019 - Deborah Wilkes

Premium

HRA Pharma has put its medicines for rare diseases into a separate affiliate, as the French company focuses on expanding its consumer healthcare business.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: